# PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative

> **NCT01916135** · PHASE1 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 11 (actual)

## Conditions studied

- Carcinoma
- Sarcoma
- Myeloma
- Lymphoma
- Melanoma

## Interventions

- **RADIATION:** [18F]-SKI-249380
- **PROCEDURE:** PET/CT scan
- **OTHER:** Blood draws

## Key facts

- **NCT ID:** NCT01916135
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2020-04-23
- **Final completion:** 2020-04-23
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2020-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01916135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01916135, "PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01916135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*